LD-2 disclosure · 4th Quarter - Report

SHIRE PHARMACEUTICALS LLC

4th Quarter (Oct 1 - Dec 31) · 2017Posted Jan 22, 2018Filing document ↗LDA record ↗

Income$53Kfee reported

Client

4 issues

Taxation/Internal Revenue Code
H.R. 1, The Tax Cut and Jobs Act, as it relates to corporate tax reform, the taxation of multinationals, and the orphan drug tax credit.
LobbyistsRACHEL JONES HENSLER · MARY BETH SAVARY TAYLOR · JEFF CHOUDHRY · EMILY PORTER · KATHERINE RAAB
Covered position (JEFF CHOUDHRY): U.S. Rep. Trent Franks, Legislative Director; U.S. Rep. Trent Franks, Legislative Assistant / Staff Assistant; House Small Business Committee, Intern
TargetedSENATE · HOUSE OF REPRESENTATIVES
Health Issues
H.R. 2368 and H.R. 878 and S. 204, Trickett Wendler, Frank Mongiello, Jordan McLinn & Matthew Bellina Right to Try Act of 2017. Issues regarding access to care for those with rare diseases.
LobbyistsMARY BETH SAVARY TAYLOR · EMILY PORTER · KATHERINE RAAB
TargetedSENATE · HOUSE OF REPRESENTATIVES
Medicare/Medicaid
H.R. 3178, Medicare Part B Improvement Act of 2017 and S. 1738, The Medicare Home Infusion Therapy Access Act of 2017 and issues related to reimbursement for home infusion. Issues related to pharmaceutical prices. Issues regarding the Self-Administered Drug (SAD) list.

LD-2 disclosure · 4th Quarter - Report

4th Quarter (Oct 1 - Dec 31) · 2017Posted Jan 22, 2018Filing document ↗LDA record ↗

Income$53Kfee reported

4 issues

Taxation/Internal Revenue Code
H.R. 1, The Tax Cut and Jobs Act, as it relates to corporate tax reform, the taxation of multinationals, and the orphan drug tax credit.
LobbyistsRACHEL JONES HENSLER · MARY BETH SAVARY TAYLOR · JEFF CHOUDHRY · EMILY PORTER · KATHERINE RAAB
Covered position (JEFF CHOUDHRY): U.S. Rep. Trent Franks, Legislative Director; U.S. Rep. Trent Franks, Legislative Assistant / Staff Assistant; House Small Business Committee, Intern
TargetedSENATE · HOUSE OF REPRESENTATIVES
Health Issues
H.R. 2368 and H.R. 878 and S. 204, Trickett Wendler, Frank Mongiello, Jordan McLinn & Matthew Bellina Right to Try Act of 2017. Issues regarding access to care for those with rare diseases.
LobbyistsMARY BETH SAVARY TAYLOR · EMILY PORTER · KATHERINE RAAB
TargetedSENATE · HOUSE OF REPRESENTATIVES
Medicare/Medicaid
H.R. 3178, Medicare Part B Improvement Act of 2017 and S. 1738, The Medicare Home Infusion Therapy Access Act of 2017 and issues related to reimbursement for home infusion. Issues related to pharmaceutical prices. Issues regarding the Self-Administered Drug (SAD) list.